Lexeo Therapeutics Inc (LXEO)

Dec 20, 2024

BNP Paribas Financial Markets Increases Stake in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Dec 20, 2024

Dec 20, 2024

When (LXEO) Moves Investors should Listen - Stock Traders Daily

Dec 20, 2024

Dec 19, 2024

Charles Schwab Investment Management Inc. Buys 33,013 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - Defense World

Dec 19, 2024

Dec 19, 2024

Lexeo Therapeutics appoints new CFO amid growth - Investing.com

Dec 19, 2024

Dec 19, 2024

Lexeo Therapeutics Appoints Dr. Kyle Rasbach as CFO - TipRanks

Dec 19, 2024

Dec 19, 2024

Lexeo Therapeutics Names Kyle Rasbach Chief Financial Officer - MarketWatch

Dec 19, 2024

Dec 19, 2024

Lexeo Therapeutics Appoints Kyle Rasbach as Chief Financial Officer - The Manila Times

Dec 19, 2024

Dec 19, 2024

Lexeo Therapeutics, Inc. Appoints Kyle Rasbach as Chief Financial Officer - Marketscreener.com

Dec 19, 2024

Dec 17, 2024

Lexeo Therapeutics' SWOT analysis: gene therapy stock's potential and pitfalls - Investing.com

Dec 17, 2024

Dec 10, 2024

Lexeo Therapeutics' SWOT analysis: gene therapy stock poised for catalysts By Investing.com - Investing.com Nigeria

Dec 10, 2024

Dec 10, 2024

Lexeo Therapeutics' SWOT analysis: gene therapy stock poised for catalysts - Investing.com India

Dec 10, 2024

Dec 10, 2024

Frazier Life Sciences Management L.P. Invests $11.31 Million in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - MarketBeat

Dec 10, 2024

Dec 10, 2024

Point72 Asset Management L.P. Makes New $3.35 Million Investment in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - MarketBeat

Dec 10, 2024

Dec 07, 2024

Janus Henderson Group PLC Purchases 599,203 Shares of Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - MarketBeat

Dec 07, 2024

Dec 05, 2024

RA Capital Management L.P. Reduces Position in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - MarketBeat

Dec 05, 2024

Dec 03, 2024

LXEOLexeo Therapeutics, Inc. Latest Stock News & Market Updates - StockTitan

Dec 03, 2024

Dec 02, 2024

Verition Fund Management LLC Boosts Stake in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - MarketBeat

Dec 02, 2024

Nov 30, 2024

Eventide Asset Management LLC Has $16.78 Million Holdings in Lexeo Therapeutics, Inc. (NASDAQ:LXEO) - MarketBeat

Nov 30, 2024

Nov 30, 2024

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Shares Sold by Braidwell LP - MarketBeat

Nov 30, 2024

Nov 28, 2024

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat

Nov 28, 2024

Nov 28, 2024

Insider Spends US$105k Buying More Shares In Lexeo Therapeutics - Simply Wall St

Nov 28, 2024

Nov 28, 2024

Paula H. Cholmondeley Bought 96% More Shares In Lexeo Therapeutics - Yahoo Finance

Nov 28, 2024

Nov 28, 2024

Lexeo Therapeutics, Inc. (NASDAQ:LXEO) Receives Average Rating of "Buy" from Analysts - MarketBeat

Nov 28, 2024

Nov 27, 2024

Insider Buying: Paula Cholmondeley Acquires 15,000 Shares of Lex - GuruFocus.com

Nov 27, 2024

Nov 24, 2024

Can Lexeo's HEROIC-PKP2 Data Reignite Stock Rally? - RTTNews

Nov 24, 2024

Nov 20, 2024

Lexeo stock hits 52-week low at $5.8 amid market challenges - Investing.com India

Nov 20, 2024

Nov 20, 2024

Here's Why We're Watching Lexeo Therapeutics' (NASDAQ:LXEO) Cash Burn Situation - Yahoo Finance

Nov 20, 2024

Nov 18, 2024

(LXEO) Trading Advice - Stock Traders Daily

Nov 18, 2024

Nov 18, 2024

Lexeo Therapeutics (NASDAQ:LXEO) Stock Price Expected to Rise, HC Wainwright Analyst Says - Defense World

Nov 18, 2024

Nov 18, 2024

FY2024 EPS Forecast for Lexeo Therapeutics Cut by Analyst - MarketBeat

Nov 18, 2024

Nov 18, 2024

FY2024 Earnings Estimate for LXEO Issued By Leerink Partnrs - MarketBeat

Nov 18, 2024

Nov 18, 2024

HC Wainwright Has Negative Estimate for LXEO FY2024 Earnings - MarketBeat

Nov 18, 2024

Nov 15, 2024

Lexeo Therapeutics (NASDAQ:LXEO) Stock Price Expected to Rise, Chardan Capital Analyst Says - Defense World

Nov 15, 2024

Nov 14, 2024

Lexeo Therapeutics Advances Cardiac Portfolio Amid Financial Report - TipRanks

Nov 14, 2024

Nov 14, 2024

Janus Henderson Group PLC's Strategic Acquisition in Lexeo Thera - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Eventide Asset Management's Strategic Reduction in Lexeo Therape - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Lexeo Therapeutics, Inc. Appoints Tolga Tanguler to Its Board of Directors - Marketscreener.com

Nov 14, 2024

Nov 13, 2024

Lexeo Therapeutics Strengthens Leadership with New Board Appointment - TipRanks

Nov 13, 2024

Nov 13, 2024

Lexeo Therapeutics Provides Update on Cardiac Portfolio and Reports Third Quarter 2024 Financial Results - The Manila Times

Nov 13, 2024

Nov 13, 2024

Lexeo Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com

Nov 13, 2024

Nov 13, 2024

Lexeo Therapeutics Secures FDA Alignment, Reports $157M Cash Position Despite Q3 Loss | LXEO Stock News - StockTitan

Nov 13, 2024

Nov 11, 2024

Lexeo stock hits 52-week low at $7.54 amid market challenges By Investing.com - Investing.com South Africa

Nov 11, 2024

Nov 11, 2024

Lexeo stock hits 52-week low at $7.54 amid market challenges - Investing.com India

Nov 11, 2024

Nov 04, 2024

Lexeo Therapeutics' Gene Therapy LX1001 Increases APOE2 Expression in Patients With Alzheimer Disease - CGTLive™

Nov 04, 2024

Nov 03, 2024

Analysts Set Lexeo Therapeutics, Inc. (NASDAQ:LXEO) PT at $22.14 - MarketBeat

Nov 03, 2024

Oct 31, 2024

Lexeo Therapeutics (NASDAQ:LXEO) Earns Buy Rating from HC Wainwright - MarketBeat

Oct 31, 2024

Oct 31, 2024

Lexeo shares dip on early data with Alzheimer's gene therapy - pharmaphorum

Oct 31, 2024

Oct 31, 2024

Lexeo reports positive Alzheimer's drug trial results - Investing.com India

Oct 31, 2024

Oct 30, 2024

Lexeo reports positive Alzheimer's drug trial results By Investing.com - Investing.com South Africa

Oct 30, 2024

Oct 30, 2024

Lexeo Therapeutics Announces Positive Interim Data for - GlobeNewswire

Oct 30, 2024

Oct 30, 2024

How now, tau? ‘Newer science’ shines in Lexeo Alzheimer’s data - BioWorld Online

Oct 30, 2024